Hiroshi Ishiba

Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non‐alcoholic fatty liver disease and type 2 diabetes mellitus

Yuya Seko, Yoshio Sumida, Saiyu Tanaka et al. · Hepatology Research · 2016 · 89 citations

Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease

Yoshio Sumida, Kazuyuki Kanemasa, Shunsuke Imai et al. · Journal of Gastroenterology · 2015 · 85 citations

Metabolic Associated Steatohepatitis, Hepatology, Nonalcoholic Fatty Liver Disease +13

Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease

Yoshio Sumida, Yoshikazu Yonei, Saiyu Tanaka et al. · Hepatology Research · 2014 · 82 citations

Development of hepatocellular carcinoma in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease: Association between PNPLA3 genotype and hepatocarcinogenesis/fibrosis progression

Yuya Seko, Yoshio Sumida, Saiyu Tanaka et al. · Hepatology Research · 2016 · 80 citations

Effect of 12‐week dulaglutide therapy in Japanese patients with biopsy‐proven non‐alcoholic fatty liver disease and type 2 diabetes mellitus

Yuya Seko, Yoshio Sumida, Saiyu Tanaka et al. · Hepatology Research · 2016 · 79 citations